Tofisopam
| CAS No. | 22345-47-7 | Cat. No. | BCP09600 |
| Name | Tofisopam | ||
| Synonyms | EGYT-341;EGYT341;EGYT 341; | ||
| Formula | C22H26N2O4 | M. Wt | 382.45 |
| Description | Tofisopam is a 2, 3-benzodiazepine drug which is a benzodiazepine derivative. In contrast to classical 1, 4-benzodiazepines, the compound does not bind to the benzodiazepine binding site of the gamma-aminobutyric acid receptor and its psychopharmacological profile differs from such compounds. Although Tofisopam is not approved for sale in North America, it is approved for use in various countries worldwide, including parts of Europe. The D-enantiomer (dextofisopam) is currently in phase II trials in the U. S. for the treatment of irritable bowel syndrome. | ||
| Pathways | Ion Channel/Membrane Transporter Neuro Signaling Pathway | ||
| Targets | GABA Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.